Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study von Landsberg, Wally, Al-Dakkak, Imad, Coppin-Renz, Antonia, Geis, Uli, Peters-Strickland, Timothy, van Heumen, Emiel, Rahman, Mirza

Volltext

Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-control... von Fleischhacker, W. Wolfgang, Heikkinen, Martti E., Olié, Jean-Pierre, Landsberg, Wally, Dewaele, Patricia, McQuade, Robert D., Loze, Jean-Yves, Hennicken, Delphine, Kerselaers, Wendy

Volltext

Defining the minimal clinically important difference (MCID) of the Heinrichs-carpenter quality of life scale (QLS) von Falissard, Bruno, Sapin, Christophe, Loze, Jean-Yves, Landsberg, Wally, Hansen, Karina

Volltext

Defining the minimal clinically important difference (MCID) of the Heinrichs-carpenter quality of life scale (QLS): MCID for QLS von Falissard, Bruno, Sapin, Christophe, Loze, Jean-Yves, Landsberg, Wally, Hansen, Karina

Volltext

Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis von De Hert, Marc, Eramo, Anna, Landsberg, Wally, Kostic, Dusan, Tsai, Lan-Feng, Baker, Ross A

Volltext

Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania von Ostacher, Michael J, Suppes, Trisha, Swann, Alan C, Eudicone, James M, Landsberg, Wally, Baker, Ross A, Carlson, Berit X

Volltext

THE EFFECT OF ARIPIPRAZOLE ON METABOLIC PARAMETERS IN CLOZAPINE-TREATED PATIENTS: RESULTS FROM A STUDY OF ADJUNCTIVE TREATMENT WITH ARIPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA von Wolfgang Fleishhacker, W, Heikkinen, Martti E, Olié, Jean-Pierre, Landsberg, Wally, Dewaele, Patricia, McQuade, Robert D, Hennicken, Delphine, Peyro-Saint-Paul, Helene, Baker, Ross A, Assunção-Talbott, Sheila

Volltext